| Scientific Session Past Presenters | ||
|---|---|---|
| 2025 | Andrew Saykin, PsyD | Precision Health Strategies for Alzheimer's Disease and Related Dementias: From Systems Biology to Biomarkers and Therapeutic Targets |
| 2025 | Julie Schneider, MD | Hippocampal Breakdown at the Crossroads of Proteinopathy and Inflammation in Aging |
| 2025 | Elizabeth Rhodus, PhD | Creating Harmony While Living with Dementia |
| 2025 | Peter Nelson, MD, PhD | The Amyloid Cascade Hypothesis: Arguments for and Against, With Public Health Implications |
| 2024 | Charles DeCarli, MD | Systemic Inflammation, Endothelial Injury and Extracellular Vesicle Signaling in Cerebrovascular Disease |
| 2024 | Lance Johnson, PhD | Flipping the switch on APO: AD-relevant effects of E4 replacement with E2 |
| 2024 | Erin Abner, PhD | Decades of discovery: harnessing UK ADRC resources to advance Alzheimer's research, diagnosis, and care |
| 2023 | Malu Tansey, PhD | Targeting Chronic Inflammation and the Gut-Brain Axisto Reduce Risk for Neurodegeneration |
| 2023 | David Morgan, PhD | Immune Activation in Models of Tauopathy |
| 2023 | Anika Hartz, PhD | Blood-Brain Barrier Repair to Improve Cognition in Alzheimer’s Disease |
| 2023 | David Fardo, PhD | A Genome-wide Association Study of Neuropathological Endophenotypes |
| 2022 | Ann McKee, MD | CTE: What Is It? What Is Its Relationship to Repetitive Head Impacts? |
| 2022 | Josh Grill, PhD | Preclinical Alzheimer’s Disease: Translating Cutting Edge Research into Everyday Practice |
| 2022 | Kate Foley, PhD | The Role of Human Plasma Biomarkers in the Diagnosis of Dementia |
| 2022 | Mark Ebbert, PhD | Using Long-Read Sequencing Technologies to Identify Key Drivers and Biomarkers in Alzheimer’s Disease |
| 2022 | Ryan Shahidehpour, Graduate Student and TRIAD T32 Trainee, | The Role of Dystrophic Microglia in Neurodegenerative Diseases Related to Aging |
| 2022 | Christopher Norris, PhD | Strategies for Targeting Astrocyte Reactivity in Alzheimer’s Disease and Related Dementias (STAR-AD/ADRD) |
| 2021 | Frederick A. Schmitt, PhD | 35 Years of the University of Kentucky Alzheimer’s DiseaseCenter: Past Discoveries and Future Directions |
| 2021 | Maj-Linda Selenica, PhD | Investigating the role of hypusinated eIF5A in AD and relatedTDP-43 proteinopathy disorders |
| 2021 | Josh Morganti, PhD | Diversity and susceptibility of microglial responses in a mousemodel of mixed etiology dementia |
| 2020 | Ronald Petersen, MD, PhD | Is MCI Still a Viable Construct in 2020? |
| 2020 | Alison Goate, D.Phil. | Human Genetics Implicates Efferocytosis in Alzheimer’s Disease |
| 2019 | Adam Brickman, PhD | Reconsidering Harbingers of Alzheimer’s Disease: Risk Factors, Biomarkers, and White Matter Hyperintensities |
| 2019 | Olivier Thibault, PhD | Ups and Downs of Calcium in Models of Aging and AD |
| 2019 | Jenna Gollihue, PhD | Manipulating Astrocytes for Better Brain Health |
| 2019 | Kendra Hargis-Staggs, PhD | Gray and White Matter Neurovascular Ceruloplasmin Expression in Alzheimer’s Disease |
| 2019 | Daniel C. Lee, PhD | Emerging Role of the Polyamine Stress Response in Alzheimer’s Disease |
| 2018 | Monica W. Parker, MD | Engaging the underserved in brain health and research |
| 2018 | Sanjay Asthana, MD, FACP | Preclinical biomarkers of Alzheimer’s disease: emerging concepts & clinical utility |
| 2018 | Donna Wilcock, PhD | Identification of novel fluid biomarkers for vascular cognitive impairment and dementia (VCID) |
| 2018 | Lance Johnson, PhD | Metabolic reprogramming and Alzheimer’s disease risk: the role of ApoE4 |
| 2018 | Elizabeth Head, PhD | Changes in cerebrovascular pathology as a function of age and Alzheimer disease in Down syndrome |
| 2018 | Dr. Gregory Jicha, MD, PhD | Modulation of micro-RNA pathways by gemfibrozil in predementia Alzheimer disease: clinical translational research at Sanders-Brown Center on Aging |
| Community Session Past Presenters | ||
|---|---|---|
| 2025 | Andrew Saykin, PsyD | The Road to Personalized Medicine for Alzheimer’s Disease and Related Dementias |
| 2025 | Julie Schneider, MD | Dementia and the Aging Brain: Pathology, Risk, and Keeping Memories Alive |
| 2025 | Erin Abner, PhD | The Case for Public Trust in Alzheimer’s Research |
| 2025 | Gregory Jicha, MD, PhD | 21st Century Breakthroughs in the Diagnosis and Treatment of Alzheimer’s and Related Disorders |
| 2024 | Lisa Barnes, PhD | Factors That Shape Brain Health and Risk of Alzheimers Disease in Older Adults |
| 2024 | Charlie DeCarli, MD | Lifes Essential 8: What You Can Do To Improve Your Brain Health |
| 2024 | Shannon Macauley, PhD | Understanding Sleep Loss in Alzheimer’s Disease |
| 2024 | Gregory Jicha, MD, PhD | Update on AD Clinical Trials at the University of Kentucky |
| 2023 | Malu Tansey, PhD | Why Gut Health Matters for Brain Health |
| 2023 | David Morgan, PhD | Immunotherapy for Alzheimer’s Disease: 25 Years from Mouse Models to Approved Treatment in People Living with Alzheimer’s |
| 2023 | Alaine Reschke-Hernandez, PhD | MT-BC" Harmonizing Music Therapy Research in Dementia Care |
| 2023 | Frederick Schmitt, PhD | Trisomy 21: Providing Insights into Dementia |
| 2023 | Gregory Jicha, MD, PhD | Anti-Amyloid Therapy: Who’s Benefitting and How Do We Move Forward? |
| 2022 | Josh Grill, PhD | Can We Prevent Alzheimer’s? |
| 2022 | Ann McKee, MD | The Inconvenient Truth About Football |
| 2022 | Lauren Whitehurst, PhD | “Memory Bright”: Research on the Cost of Racial Sleep Disparities for Memory Processing" |
| 2022 | Elizabeth Rhodus, PhD | Creating Harmony While Caring for People Living with Dementia |
| 2021 | Allan Levey, MD | Accelerating Progress for Treatments for Alzheimer’s Disease? |
| 2021 | Gregory Jicha, MD, PhD & Erin Abner, PhD | Aducanamab / Aduhelm: The controversial new treatment for Alzheimer’s disease |
| 2020 | Maria Carrillo, PhD | Advancing the Science: The Latest in Alzheimer’s and Dementia Research |
| 2020 | Daniel Moga | My Medications and Why Should I Know about Them |
| 2020 | Peter Nelson, MD, PhD | LATE: What It Is, Why It's Important, and How We Might Beat It |
| 2019 | Laura D. Baker, PhD | Can LIFESTYLE Impact Health of the Mind As We Age? |
| 2019 | Gregory Jicha, MD, PhD | Clinical Trials Update |
| 2018 | Sanjay Asthana, MD, FACP | Early Diagnosis and Prevention of Alzheimer’s Disease: Role of Biomarkers and Estrogen Hormone |
| 2018 | Monica W. Parker, MD | Alzheimer’s and The Brain: What We Know |